We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$24.6B
AUM Growth
-$4.32B
(-15%)
Cap. Flow
-$4.58B
Cap. Flow
% of AUM
-18.6%
Top 10 Holdings %
Top 10 Hldgs %
35.76%
Holding
1,158
New
25
Increased
204
Reduced
826
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$417M |
| 2 |
Tesla
TSLA
|
+$152M |
| 3 |
Broadcom
AVGO
|
+$74.2M |
| 4 |
Qualcomm
QCOM
|
+$39.4M |
| 5 |
Marvell Technology
MRVL
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$341M |
| 3 |
Applied Materials
AMAT
|
+$243M |
| 4 |
Lam Research
LRCX
|
+$194M |
| 5 |
NVIDIA
NVDA
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.84% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Healthcare | 3.78% |
| 5 | Industrials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Amalgamated Financial
AMAL
$1.4B
| $682K | ﹤0.01% |
17,548
-5,046
| -22% | -$191K |
|
|
PURR
852
Hyperliquid Strategies Inc
PURR
$1.39B
| $676K | ﹤0.01% |
+132,782
| New | +$601K |
|
853
Baxter International
BAX
$11.4B
| $668K | ﹤0.01% |
39,755
-15,590
| -28% | -$302K |
|
854
4D Molecular Therapeutics
FDMT
$593M
| $665K | ﹤0.01% |
71,396
-12,017
| -14% | -$105K |
|
|
FFIC
855
DELISTED
Flushing Financial
FFIC
| $653K | ﹤0.01% |
42,509
+10,374
| +32% | +$162K |
|
856
Casey's General Stores
CASY
$31.9B
| $648K | ﹤0.01% |
890
-420
| -32% | -$274K |
|
857
Quanex
NX
$848M
| $644K | ﹤0.01% |
35,827
-6,369
| -15% | -$120K |
|
858
Vanda Pharmaceuticals
VNDA
$329M
| $638K | ﹤0.01% |
+92,304
| New | +$712K |
|
|
FSUN
859
FirstSun Capital Bancorp
FSUN
$1.58B
| $634K | ﹤0.01% |
17,394
-870
| -5% | -$33K |
|
860
NB Bancorp
NBBK
$912M
| $632K | ﹤0.01% |
29,998
+5,802
| +24% | +$122K |
|
861
Bio-Techne
TECH
$11.2B
| $632K | ﹤0.01% |
12,092
-4,684
| -28% | -$281K |
|
862
Regenxbio
RGNX
$562M
| $619K | ﹤0.01% |
73,878
+14,679
| +25% | +$154K |
|
863
J.M. Smucker
SJM
$12.5B
| $616K | ﹤0.01% |
6,386
-2,548
| -29% | -$267K |
|
864
Zoom
ZM
$25.3B
| $590K | ﹤0.01% |
7,341
-1,161
| -14% | -$97.2K |
|
865
Univest Financial
UVSP
$1.22B
| $588K | ﹤0.01% |
17,171
+3,688
| +27% | +$125K |
|
866
Lexeo Therapeutics
LXEO
$372M
| $579K | ﹤0.01% |
100,896
-1,263
| -1% | -$8.95K |
|
867
Verastem
VSTM
$506M
| $578K | ﹤0.01% |
109,123
-20,210
| -16% | -$125K |
|
868
Central Pacific Financial
CPF
$1.01B
| $571K | ﹤0.01% |
17,873
-2,848
| -14% | -$91.8K |
|
869
Henry Schein
HSIC
$9.66B
| $570K | ﹤0.01% |
7,733
-3,041
| -28% | -$235K |
|
870
Dream Finders Homes
DFH
$1.4B
| $569K | ﹤0.01% |
40,844
-6,169
| -13% | -$110K |
|
871
Okta
OKTA
$24B
| $557K | ﹤0.01% |
7,073
-1,133
| -14% | -$94K |
|
872
Amerant Bancorp
AMTB
$994M
| $555K | ﹤0.01% |
25,183
-12,747
| -34% | -$274K |
|
873
Burlington
BURL
$22.3B
| $554K | ﹤0.01% |
1,704
-693
| -29% | -$212K |
|
874
Arbutus Biopharma
ABUS
$867M
| $553K | ﹤0.01% |
122,854
+5,822
| +5% | +$25.5K |
|
875
News Corp Class A
NWSA
$14.9B
| $552K | ﹤0.01% |
22,156
-9,206
| -29% | -$228K |
|
Similar funds
CS
AF
SC
RG
JG
Rafferty Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Rafferty Asset Management held 1,158 positions worth $24.6B, down 15% from $28.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Rafferty Asset Management withdrew a net $4.58B in Q1 2026, closing 101 positions and reducing 826 holdings. Its most notable exit was AstraZeneca, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in FTAI Aviation worth $6.39M.
- Rafferty Asset Management's largest Q1 2026 buy was FTAI Aviation: 26,098 shares worth $6.39M.
- Rafferty Asset Management added most to iShares MSCI South Korea ETF in Q1 2026, an estimated $417M increase.
- Rafferty Asset Management's biggest Q1 2026 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $647M.
- Rafferty Asset Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.3M.
- Rafferty Asset Management's ten largest holdings make up 36% of its $24.6B portfolio in Q1 2026.
- Rafferty Asset Management opened 25 new positions and closed 101 in Q1 2026.
- Rafferty Asset Management's portfolio value fell 15% quarter-over-quarter to $24.6B.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.